Clinical Trial Update: Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update showing completion of consolidation therapy with bortezomib in elderly patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED